ARYx TherapeuticsFremont, CA, United States (NASDAQ (GM): ARYX)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

ARYx Income Statement

All amounts in millions of except per share amounts.
View: Annual
Dec 07 Dec 06 Dec 05
Revenue 4.2 4.7 0.0
Cost of Goods Sold 0.3 2.1 --
Gross Profit 3.9 2.6 --
Gross Profit Margin 93.8% 55.3% 0.0%
SG&A Expense 31.5 30.0 27.2
Depreciation & Amortization 1.2 0.9 1.0
Operating Income (28.8) (28.3) (28.2)
Operating Margin -- -- --
Nonoperating Income 2.6 2.3 0.9
Nonoperating Expenses 1.4 1.3 0.7
Income Before Taxes (27.6) (27.3) (28.0)
Income Taxes -- -- --
Net Income After Taxes (27.6) (27.3) (28.0)

Continuing Operations (27.6) (27.3) (28.0)
Discontinued Operations -- -- --
Total Operations (27.6) (27.3) (28.0)
Total Net Income (27.6) (27.3) (28.0)
Net Profit Margin -- -- --

Diluted EPS from Total Net Income ($) (8.24) (26.84) (30.73)
Dividends per Share -- -- --
Edgar Online logo
This data is provided as per license from EDGAR Online